Protein Frontiers ApS
CVR 43132709 · Private limited company (ApS) · Active · Low risk
Protein Frontiers ApS is a Private limited company (ApS), founded on , based in Gentofte. The company is registered in the industry forskning og eksperimentel udvikling inden for naturvidenskab og teknik. Our model estimates a bankruptcy risk of 0.5% over the next 12 months, which is 0.4 times the average for Danish companies. 4 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 1.2m and a net result of DKK -149k. CEO: Henrik Sønksen.
Bankruptcy risk for Protein Frontiers ApS
0.4 × the average (1.41%) · higher risk than 60% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 43132709
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (4 years)
- Address
- c/o Henrik Sønksen, C L Ibsens Vej 7, st.
2820 Gentofte - Municipality
- Gentofte
- Industry
- Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)
Bankruptcies in the industry: Anden forskning og eksperimentel udvikling inden for naturvidenskab og teknik - Share capital
- DKK 125k
- Auditor
- PricewaterhouseCoopersStatsautoriseret Revisionspartnerselskab
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 4 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 54.8% |
| Current ratio | 221% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 5 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK 513k | DKK 768k |
| Net profit | DKK -149k | DKK 601k |
| Equity | DKK 1.2m | DKK 1.1m |
| Total assets | DKK 2.2m | DKK 1.1m |
| Cash | DKK 945k | – |
| Short-term debt | DKK 977k | – |
| Tax owed | DKK 0 | – |
| Avg. employees | 1 | – |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · PricewaterhouseCoopersStatsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 163 | ||
| 1 Jan 2024 – 31 Dec 2024 | 170 | ||
| 1 Jan 2023 – 31 Dec 2023 | 180 | ||
| 10 Mar 2022 – 31 Dec 2022 | 181 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Henrik Sønksen | Current | |
| Board | Henrik Sønksen | Current | |
| Board | Lasse Solheim Hansen | Current | |
| Board | Niels Kristian Sørensen | Current | |
| Board | Peter Lübeck | Current | |
| Board | Mette Lübeck | Current | |
| Board | Hans Peder Morten Laursen Meldgaard | Current | |
| Owner (20%) | MPLU Biorefining Aps | Current | |
| Owner (20%) | NKS Investment ApS | Current | |
| Owner (20%) | H Sønksen Holding ApS | Current | |
| Owner (20%) | Solheim22 Holding ApS | Current | |
| Owner (20%) | Viridis Futurum ApS | Current | |
| Founder | MPLU Biorefining Aps | Current | |
| Founder | NKS Investment ApS | Current | |
| Founder | H Sønksen Holding ApS | Current | |
| Founder | Solheim22 Holding ApS | Current |
The CEOs' other companies
Henrik Sønksen – 11 other companies, of which 6 bankrupt
- GARTNERISELSKABET AF 13. MAJ 2009 A/S Bankrupt 17 Jun 2009
- Gartneriet af 01.12.2019 ApS Bankrupt 13 Dec 2019
- LADING-FAJSTRUP KRAFTVARMEVÆRK A/S Bankrupt 14 Dec 2009
- ROSES FOREVER NETWORK SERVICE ApS Bankrupt 11 Nov 2009
- Selskabet af 15. juni 2019 ApS Bankrupt 4 Jul 2019
- SØRIS A/S Bankrupt 29 Oct 2025
- H Sønksen Holding ApS Active
- PL-PRODUCTION ApS Compulsorily dissolved
- Pulito ApS Active
- ROSA HOLDING ApS Active
- ROSES FOREVER ApS Active
Address history (2 moves)
| c/o Henrik Sønksen, C L Ibsens Vej 7, st., 2820 Gentofte | |
| c/o Henrik Sønksen, C L Ibsens Vej 7, st., 2820 Gentofte | |
| c/o Henrik Sønksen, Fordresgårdvej 36, 2400 København NV |
Other companies at the same address
- Asche Holding ApS Active
- H Sønksen Holding ApS Active
- Pulito ApS Active
- REBEL FOOD ApS Active
- Street & Food ApS Opløst
Similar companies in Gentofte
- Lica Pharma ApS Hellerup
- SKN computation ApS Gentofte
- WinQure Medicine ApS Klampenborg
- Illum Biotech ApS Charlottenlund
- Novo Nordisk Clinical Innovation Centre A/S Gentofte
- Bollværk ApS Hellerup
- Epitopea ApS Klampenborg
- Spectoceutics ApS Gentofte
- CENEXUM Technologies ApS Gentofte
- ClinOption ApS Dyssegård
- Ascendis Pharma Oncology Division A/S Hellerup
- Merian Life Sciences ApS Hellerup
Questions and answers about Protein Frontiers ApS
Has Protein Frontiers ApS gone bankrupt?
No, Protein Frontiers ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Protein Frontiers ApS?
Our model estimates a bankruptcy risk of 0.5% over the next 12 months (low risk), which is 0.4 times the average for Danish companies.
Who is the CEO of Protein Frontiers ApS?
Henrik Sønksen is the CEO of Protein Frontiers ApS.
Who is the auditor of Protein Frontiers ApS?
Protein Frontiers ApS most recently used PricewaterhouseCoopersStatsautoriseret Revisionspartnerselskab.
When was Protein Frontiers ApS founded?
Protein Frontiers ApS was founded on 10 March 2022.
What is the equity of Protein Frontiers ApS?
Equity was DKK 1.2m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.